Christopher Causey, Director at UNITED THERAPEUTICS Corp (UTHR), sold 580 shares at $122.00 ($71K) on 2017-11-06, disclosed to the SEC on 2017-11-07.
Seasonal sale ($71k) by Director — this insider has traded UTHR in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| UTHR | SELL | 2026-02-25 | $520K | — | Filing → |
| UTHR | SELL | 2026-01-06 | $510K | — | Filing → |
| UTHR | SELL | 2026-01-05 | $500K | — | Filing → |